Disclosure of Data. RMS shall promptly provide to Pharmaceutical Partners copies of or access to all Clinical Patient Data held by RMS, and all related supporting documentation, information, results, analyses with respect to RMS’ activities under the Project Plan, when and as such Clinical Patient Data or supporting documentation or other information becomes available.
Appears in 4 contracts
Samples: Companion Diagnostics Agreement (Epizyme, Inc.), Companion Diagnostics Agreement, Companion Diagnostics Agreement (Epizyme, Inc.)